Chemistry:Protamine sulfate
| Clinical data | |
|---|---|
| Trade names | Prosulf, others |
| AHFS/Drugs.com | Monograph |
| Pregnancy category |
|
| Routes of administration | IV |
| Pharmacokinetic data | |
| Onset of action | 5 minutes[1] |
| Identifiers | |
| CAS Number | |
| DrugBank | |
| UNII | |
Protamine sulfate is a medication that is used to reverse the effects of heparin.[2] It is specifically used in heparin overdose, in low molecular weight heparin overdose, and to reverse the effects of heparin during delivery and heart surgery.[2][3] It is given by injection into a vein.[2] The onset of effects is typically within five minutes.[1]
Common side effects include low blood pressure, slow heart rate, allergic reactions, and vomiting.[2] Allergic reactions may be severe and include anaphylaxis.[2] The risk is greater in males who have had a vasectomy.[4] While there is no evidence of harm from using during pregnancy it has not been well studied in this group.[5] Protamine works by binding with heparin.[2]
Protamine sulfate was approved for medical use in the United States in 1969.[2] It is on the World Health Organization's List of Essential Medicines.[6] It was originally made from the sperm of salmon (salmine, salmon protamine).[2] It is now mainly made using recombinant biotechnology.[7]
Medical uses
Protamine sulfate is usually administered to reverse the large dose of heparin administered during certain surgeries, especially heart surgery where anti-coagulation is necessary to prevent clot formation within the cardiopulmonary bypass pump apparatus. A dose of protamine is given, by drip administered over several minutes, once the patient is off-pump, when extracorporeal circulation and anticoagulation are no longer needed.
It is also used in gene transfer, protein purification and in tissue cultures as a crosslinker for viral transduction. In gene therapy, protamine sulfate has been studied as a means to increase transduction rates by both viral and nonviral-mediated delivery mechanisms (e.g. utilizing cationic liposomes).[8][9]
Protamine is used in insulin aspart protamine and NPH insulin.
Dosage
Dosage for heparin reversal is 0.5mg to 1.0 mg mg protamine sulfate IV for every 100 IU of active heparin. Partial thromboplastin time (PTT) should be monitored at 5 to 15 minutes after dose then in 2–8 hours afterward.
Adverse effects
Protamine has been reported to cause allergic reactions in patients who are allergic to fish, diabetics using insulin preparations containing protamine, and vasectomized or infertile men.[10][11] These occur at rates ranging from 0.28% to 6%.[11][12][13]
Avoiding rapid infusion of protamine sulfate and pre-treating at-risk patients with histamine receptor antagonists (H1 and H2) and steroids may minimize these reactions. A 5 to 10 mg test dose is recommended following pretreatment before administering the full dose.[11]
Mechanism
It is a highly cationic peptide that binds to either heparin or low molecular weight heparin (LMWH) to form a stable ion pair, which does not have anticoagulant activity. The ionic complex is then removed and broken down by the reticuloendothelial system. In large doses, protamine sulfate may also have an independent — however weak — anticoagulant effect.
History
Protamine sulfate replaced hexadimethrine bromide (Polybrene), another cationic agent that was the original heparin reversal agent in the early days of heart surgery, until studies in the 1960s suggested that hexadimethrine bromide might cause kidney failure when used in doses in excess of its therapeutic range.[14]
References
- ↑ 1.0 1.1 "Prosulf 10mg/ml Solution for Injection - Summary of Product Characteristics (SPC) - (eMC)". https://www.medicines.org.uk/emc/medicine/13567.
- ↑ 2.0 2.1 2.2 2.3 2.4 2.5 2.6 2.7 "Protamine Sulfate". The American Society of Health-System Pharmacists. https://www.drugs.com/monograph/protamine-sulfate.html.
- ↑ "Protamine sulfate". https://www.drugbank.ca/drugs/DB09141.
- ↑ WHO Model Formulary 2008. World Health Organization. 2009. p. 255. ISBN 9789241547659.
- ↑ "Protamine Use During Pregnancy". Drugs.com. https://www.drugs.com/pregnancy/protamine.html.
- ↑ World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. 2019. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
- ↑ "Antithrombotic and Antiplatelet Therapy for Percutaneous Coronary Interventions" (in en). The Interventional Cardiac Catheterization Handbook E-Book. Elsevier Health Sciences. 2012. p. 131. ISBN 9781455740420. https://books.google.com/books?id=E27-2_qutX0C&pg=PA131.
- ↑ "Protamine sulfate enhances lipid-mediated gene transfer". Gene Therapy 4 (9): 961–968. September 1997. doi:10.1038/sj.gt.3300484. PMID 9349433.
- ↑ "Protamine sulfate as an effective alternative to polybrene in retroviral-mediated gene-transfer: implications for human gene therapy". Journal of Virological Methods 23 (2): 187–194. February 1989. doi:10.1016/0166-0934(89)90132-8. PMID 2786000. https://zenodo.org/record/1258363.
- ↑ "Successful cardiopulmonary bypass in diabetics with anaphylactoid reactions to protamine". British Heart Journal 52 (1): 112–114. July 1984. doi:10.1136/hrt.52.1.112. PMID 6743419.
- ↑ 11.0 11.1 11.2 "Management of the patient with protamine hypersensitivity for cardiac surgery". Anesthesiology 61 (6): 761–764. December 1984. doi:10.1097/00000542-198412000-00021. PMID 6334459.
- ↑ "Hemodynamic changes after protamine administration: association with mortality after coronary artery bypass surgery". Anesthesiology 102 (2): 308–314. February 2005. doi:10.1097/00000542-200502000-00011. PMID 15681944.
- ↑ "The toxicology of heparin reversal with protamine: past, present and future". Expert Opinion on Drug Metabolism & Toxicology 12 (8): 897–909. August 2016. doi:10.1080/17425255.2016.1194395. PMID 27223896.
- ↑ "Renal toxicity of polybrene (hexadimethrine bromide).". The Journal of Surgical Research 5 (5): 195–199. May 1965. doi:10.1016/S0022-4804(65)80086-5. PMID 14281435.
External links
- Protamine+Sulfate at the US National Library of Medicine Medical Subject Headings (MeSH)
- "Protamine Sulfate". Drug Information Portal. U.S. National Library of Medicine. https://druginfo.nlm.nih.gov/drugportal/name/protamine%20sulfate.
 |  |
